Definition and Quality Requirements for Stereotactic Radiotherapy: Consensus Statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2020 Mar 27

PMID 32211940

Citations 69

Authors

Matthias Guckenberger

Wolfgang W Baus

Oliver Blanck

Stephanie E Combs

Jurgen Debus

Rita Engenhart-Cabillic

Tobias Gauer

Anca L Grosu

Daniela Schmitt

Stephanie Tanadini-Lang

Christos Moustakis

Affiliations

Soon will be listed here.

Abstract

Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.

Citing Articles

Feasibility of Coplanar VMAT for Brain Metastases Using Halcyon With Knowledge-based Planning from Non-coplanar Plan.

Sakai Y, Kubo K, Matsumoto K, Hosono M, Monzen H In Vivo. 2025; 39(2):894-901.

PMID: 40010996 PMC: 11884445. DOI: 10.21873/invivo.13893.

Reirradiation using helical tomotherapy-based hypofractionated stereotactic radiotherapy for 19 brain metastases after the second recurrence of distant brain failure: a case report and literature review.

Wang T, Zhao H, Suwinski R, Cheng G, Guan W Transl Lung Cancer Res. 2025; 14(1):272-286.

PMID: 39958210 PMC: 11826268. DOI: 10.21037/tlcr-2024-1151.

Spatial accuracy of dose delivery significantly impacts the planning target volume margin in linear accelerator-based intracranial stereotactic radiosurgery.

Takahashi Y, Oshika R, Tachibana R, Shirai K, Asakura H, Miyazaki M Sci Rep. 2025; 15(1):3608.

PMID: 39875508 PMC: 11775166. DOI: 10.1038/s41598-025-87769-z.

Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience.

Fiore M, Petrianni G, DErcole G, Onorati E, Trecca P, Alaimo R J Clin Med. 2025; 13(24.

PMID: 39768662 PMC: 11677411. DOI: 10.3390/jcm13247739.

Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study.

Fabian A, Buergy D, Weykamp F, Horner-Rieber J, Bernhardt D, Boda-Heggemann J Clin Exp Metastasis. 2024; 42(1):6.

PMID: 39708074 PMC: 11663153. DOI: 10.1007/s10585-024-10326-x.

References

Sterzing F, Brunner T, Ernst I, Baus W, Greve B, Herfarth K . Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014; 190(10):872-81. DOI: 10.1007/s00066-014-0714-1. View

Schmitt D, Blanck O, Gauer T, Fix M, Brunner T, Fleckenstein J . Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy. Strahlenther Onkol. 2020; 196(5):421-443. PMC: 7182540. DOI: 10.1007/s00066-020-01583-2. View

Kocher M, Wittig A, Piroth M, Treuer H, Seegenschmiedt H, Ruge M . Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014; 190(6):521-32. DOI: 10.1007/s00066-014-0648-7. View

Chao S, Dad L, Dawson L, Desai N, Pacella M, Rengan R . ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2020; 43(8):545-552. DOI: 10.1097/COC.0000000000000706. View

Panje C, Andratschke N, Brunner T, Niyazi M, Guckenberger M . Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2016; 192(12):875-885. DOI: 10.1007/s00066-016-1053-1. View